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Introduction
Administrative data routinely collected at hospitals are
attractive for researchers: they are large, often exhaustive,
and of relatively easy access. However, they are not
intended for research, and they lack the clinical details of
observational studies or clinical trials. Researchers thus
face a trade-off between using large but incomplete data-
bases versus using detailed but often poorly representative
ones. One of the major limitations of missing informa-
tion in administrative data is that endogeneity cannot be
corrected due to the non-observability of the characteris-
tics of some patients.
Let us suppose that we seek to evaluate the impact of a
given treatment on a patient's health. The decision to treat
a patient is not random in real practice, contrary to what
occurs in clinical trials. In the "real world", patients are
selected into treatment arms based on their expected out-
comes. Hence, the explanatory variable (treatment) is
endogenous, as it is explained by the dependent variable
(outcome). This problem would be solved if one could
control for a large array of patients' characteristics, in
order to estimate the differences between the treated and
the untreated. Unfortunately, this is not the case with
administrative data.
In the present study, however, we postulate that appropri-
ate statistical techniques can help reduce this problem. To
do so, we examine the impact of invasive treatments for
cardio-vascular disease - percutaneous coronary interven-
tion (PCI) - and coronary artery bypass grafting (CABG)
on in-patient mortality, using administrative data from
Portuguese NHS hospitals. We examine how outcomes
vary whether we account for endogeneity or not. Then, we
examine how the selection bias spreads to other indica-
tors, namely, the differences between men's mortality and
women's mortality following invasive treatments.
Methods
We study patients admitted for cardio-vascular disease at
NHS hospitals in Portugal for the 2000-2006 period
(diagnoses were selected using ICD-9-CM codes). Since
cardio-vascular diseases are mostly treated at NHS hospi-
tals, this offers us an exhaustive data set representative of
national patterns of treatment. Patients are selected
according to their principal diagnosis and grouped
according to the HCFA-DRG classification. Our final sam-
ple includes 259,519 discharges from 57 hospitals.
First, we consider a simple probit model to measure the
impact of invasive treatment on in-patient mortality, with
in-patient mortality as a dependent binary variable (0/1),
controlling for the patient's age and comorbidities.
Indeed, our data do not provide further details on the
severity of disease (in particular, the ejection fraction and
number and type of affected vessels). Then, we estimate
the impact of treatment, controlling for endogeneity
through the use of a recursive bivariate model, which con-
sists in assuming that allocation to treatment is non-ran-
dom and endogenous to mortality.
The basic idea of the model is that mortality and treat-
ment can be thought of as two latent variables from a
bivariate normal distribution. Hence, we assume from the
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start that there is a correlation between the error terms of
both variables, i.e., that there are unobservable variables
that affect both mortality and treatment. Then, we com-
pare the findings between the simplest model and the
recursive bivariate model.
Results
Without accounting for endogeneity, we observe that
patients treated by PCI have a 51% likelihood of dying
during hospitalization. When controlling for endogene-
ity, the reduction in in-patient mortality increases to 87%.
As regards CABG, treated patients have a 12% lower mor-
tality ratio on average with the simple binomial model,
and a 76% lower mortality ratio using the recursive bivar-
iate model. In both cases, the discrepancy in results indi-
cates that the endogeneity bias is large, and that treated
patients have some characteristics which make them more
likely to die. Hence, the impact of treatment is under-esti-
mated using the simple model.
As regards the differences between men and women, we
observe a similar pattern. Women have a 3% higher like-
lihood of dying during hospitalization after PCI according
to the simplest model, for a 6% lower mortality ratio
when controlling for endogeneity. In this case, the dis-
crepancy in results is even more dramatic, since the sign of
the inequality is reversed. Similar variations are observed
for CABG.
Conclusion
Our study indicates the relevance of using appropriate sta-
tistical techniques when relying on administrative data for
clinical research. However, our outcomes also show that,
when using more sophisticated techniques, we obtain
results with administrative data that are comparable in
sign and magnitude to those obtained from observational
studies. This should encourage us to pursue investigation
using administrative data, but with a proper adjustment
for the lack of detailed patients' characteristics.Page 2 of 2
(page number not for citation purposes)
